Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:MPH NYSEARCA:VRP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMPHMedicureC$1.20-0.8%C$1.09C$0.63▼C$1.27C$12.52M0.94,080 shs10,100 shsVRPInvesco Variable Rate Preferred ETF$24.490.0%$24.30$23.03▼$24.67$2.14B0.44459,930 shs174,419 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMPHMedicure0.00%-2.44%+13.21%+33.33%-4.00%VRPInvesco Variable Rate Preferred ETF-0.12%-0.20%+0.53%+3.03%+1.37%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMPHMedicureN/AN/AN/AN/AN/AN/AN/AN/AVRPInvesco Variable Rate Preferred ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMPHMedicure 0.00N/AN/AN/AVRPInvesco Variable Rate Preferred ETF 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMPHMedicureC$21.08M0.59C$0.48 per share2.49C$1.91 per share0.63VRPInvesco Variable Rate Preferred ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMPHMedicure-C$2.03M-C$0.19N/A∞N/A-9.65%-10.18%-5.63%N/AVRPInvesco Variable Rate Preferred ETFN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMPHMedicureN/A2.24%N/AN/AN/AVRPInvesco Variable Rate Preferred ETF$1.415.76%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMPHMedicure4.652.031.29VRPInvesco Variable Rate Preferred ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMPHMedicure23.10%VRPInvesco Variable Rate Preferred ETFN/AInsider OwnershipCompanyInsider OwnershipMPHMedicure26.68%VRPInvesco Variable Rate Preferred ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMPHMedicureN/A10.44 millionN/ANot OptionableVRPInvesco Variable Rate Preferred ETFN/A87.60 millionN/ANot OptionableMPH, HZD, FARN, and VRP HeadlinesRecent News About These CompaniesTrying To Beat VRP With One Of Its Own Holdings - MS.PR.AJuly 6, 2025 | seekingalpha.comInvesco Variable Rate Preferred ETF declares monthly distribution of $0.1090June 23, 2025 | seekingalpha.comInvesco Variable Rate Preferred ETF's Portfolio BreakdownJune 13, 2025 | seekingalpha.comInvesco Variable Rate Preferred ETF declares monthly distribution of $0.1051May 21, 2025 | msn.comInvesco Variable Rate Preferred ETF declares monthly distribution of $0.1093April 22, 2025 | seekingalpha.comSay No To Fixed-Rate Preferred Stocks With VRPMarch 26, 2025 | seekingalpha.comVRP: A Preferred ETF Looking Safer Than Its PeersMarch 23, 2025 | seekingalpha.comInvesco Variable Rate Preferred ETF (VRP) Dividend HistoryMarch 21, 2025 | nasdaq.comBaird Upgrades Truist Financial Corporation - Preferred Stock (TFC.PRI)March 7, 2025 | msn.com(VRP) Long Term Investment AnalysisJanuary 21, 2025 | news.stocktradersdaily.comNInvesco Variable Rate Preferred ETF declares monthly distribution of $0.11227January 21, 2025 | msn.com2 Preferred Stock ETFs for 2025January 8, 2025 | etftrends.comEEase Any Fixed Income Angst With This Preferred ETFDecember 28, 2024 | etftrends.comEInvesco Variable Rate Preferred ETF declares monthly distribution of $0.1372December 23, 2024 | msn.com(VRP) Technical Pivots with Risk ControlsDecember 10, 2024 | news.stocktradersdaily.comN4 Invesco Fixed Income ETFs for 2025December 5, 2024 | etftrends.comEInvesco Variable Rate Preferred ETF declares monthly distribution of $0.1426November 20, 2024 | msn.comVRP: The Value May Not Justify The FeesOctober 25, 2024 | seekingalpha.comInvesco Variable Rate Preferred ETF declares monthly distribution of $0.1428October 23, 2024 | msn.comPhillip Securities Upgrades Bank of America Corporation - Preferred Stock (BAC.PRE)October 21, 2024 | msn.comMedia Sentiment Over TimeMPH, HZD, FARN, and VRP Company DescriptionsMedicure CVE:MPHC$1.20 -0.01 (-0.83%) As of 07/14/2025 12:44 PM EasternMedicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.Invesco Variable Rate Preferred ETF NYSEARCA:VRP$24.48 -0.01 (-0.02%) As of 12:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The Invesco Variable Rate Preferred ETF (VRP) is an exchange-traded fund that mostly invests in broad credit fixed income. The fund tracks a market-value-weighted index of variable- and floating-rate preferred stocks. VRP was launched on May 1, 2014 and is managed by Invesco. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters 3 Analysts Set $600 Target Ahead of Microsoft Earnings JPMorgan Q2 Results Affirm Dividend, Buybacks, & Growth NVDA Greenlight: China H20 Sales Spark 50% Rally Potential Tesla: 2 Plays Ahead of Next Week's Earnings Report New Catalyst Sends Joby Stock to 52-Week Highs Palantir Gets Price Hike From Wedbush Amid High Valuation Delta Air Lines Stock Rallies on New Guidance—Can It Keep Going? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
